News & Updates

Patients with epilepsy more commonly have minor physical anomalies (MPA), suggesting a neurodevelopmental dimension to epilepsy, a recent study has found.

Treatment with remote ischaemic conditioning in adults with acute moderate ischaemic stroke appears to increase the chances of achieving excellent neurologic function at 90 days as compared with usual care, as shown in the results of an open-label, blinded-endpoint, randomized clinical trial.

Studies presented at AAIC 2022 show that dancing could be a protective factor against the development of Alzheimer’s disease (AD) and dementia in older adults.

Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).